US 11547761
Antibody adjuvant conjugates
granted A61KA61K2039/55511A61K2039/55516
Quick answer
US patent 11547761 (Antibody adjuvant conjugates) held by Bolt Biotherapeutics, Inc. expires Mon Jan 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Bolt Biotherapeutics, Inc.
- Grant date
- Tue Jan 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 91
- CPC classes
- A61K, A61K2039/55511, A61K2039/55516, A61K2039/5555, A61K2039/55561